1 Introduction to Research & Analysis Reports
1.1 Hay Fever Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hay Fever Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hay Fever Drug Overall Market Size
2.1 Global Hay Fever Drug Market Size: 2022 VS 2029
2.2 Global Hay Fever Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hay Fever Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Hay Fever Drug Players in Global Market
3.2 Top Global Hay Fever Drug Companies Ranked by Revenue
3.3 Global Hay Fever Drug Revenue by Companies
3.4 Global Hay Fever Drug Sales by Companies
3.5 Global Hay Fever Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hay Fever Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hay Fever Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hay Fever Drug Players in Global Market
3.8.1 List of Global Tier 1 Hay Fever Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Hay Fever Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hay Fever Drug Market Size Markets, 2022 & 2029
4.1.2 Sprays
4.1.3 Drops
4.1.4 Gels
4.2 By Type – Global Hay Fever Drug Revenue & Forecasts
4.2.1 By Type – Global Hay Fever Drug Revenue, 2018-2023
4.2.2 By Type – Global Hay Fever Drug Revenue, 2024-2029
4.2.3 By Type – Global Hay Fever Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Hay Fever Drug Sales & Forecasts
4.3.1 By Type – Global Hay Fever Drug Sales, 2018-2023
4.3.2 By Type – Global Hay Fever Drug Sales, 2024-2029
4.3.3 By Type – Global Hay Fever Drug Sales Market Share, 2018-2029
4.4 By Type – Global Hay Fever Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hay Fever Drug Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Hay Fever Drug Revenue & Forecasts
5.2.1 By Application – Global Hay Fever Drug Revenue, 2018-2023
5.2.2 By Application – Global Hay Fever Drug Revenue, 2024-2029
5.2.3 By Application – Global Hay Fever Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Hay Fever Drug Sales & Forecasts
5.3.1 By Application – Global Hay Fever Drug Sales, 2018-2023
5.3.2 By Application – Global Hay Fever Drug Sales, 2024-2029
5.3.3 By Application – Global Hay Fever Drug Sales Market Share, 2018-2029
5.4 By Application – Global Hay Fever Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hay Fever Drug Market Size, 2022 & 2029
6.2 By Region – Global Hay Fever Drug Revenue & Forecasts
6.2.1 By Region – Global Hay Fever Drug Revenue, 2018-2023
6.2.2 By Region – Global Hay Fever Drug Revenue, 2024-2029
6.2.3 By Region – Global Hay Fever Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Hay Fever Drug Sales & Forecasts
6.3.1 By Region – Global Hay Fever Drug Sales, 2018-2023
6.3.2 By Region – Global Hay Fever Drug Sales, 2024-2029
6.3.3 By Region – Global Hay Fever Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hay Fever Drug Revenue, 2018-2029
6.4.2 By Country – North America Hay Fever Drug Sales, 2018-2029
6.4.3 US Hay Fever Drug Market Size, 2018-2029
6.4.4 Canada Hay Fever Drug Market Size, 2018-2029
6.4.5 Mexico Hay Fever Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hay Fever Drug Revenue, 2018-2029
6.5.2 By Country – Europe Hay Fever Drug Sales, 2018-2029
6.5.3 Germany Hay Fever Drug Market Size, 2018-2029
6.5.4 France Hay Fever Drug Market Size, 2018-2029
6.5.5 U.K. Hay Fever Drug Market Size, 2018-2029
6.5.6 Italy Hay Fever Drug Market Size, 2018-2029
6.5.7 Russia Hay Fever Drug Market Size, 2018-2029
6.5.8 Nordic Countries Hay Fever Drug Market Size, 2018-2029
6.5.9 Benelux Hay Fever Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hay Fever Drug Revenue, 2018-2029
6.6.2 By Region – Asia Hay Fever Drug Sales, 2018-2029
6.6.3 China Hay Fever Drug Market Size, 2018-2029
6.6.4 Japan Hay Fever Drug Market Size, 2018-2029
6.6.5 South Korea Hay Fever Drug Market Size, 2018-2029
6.6.6 Southeast Asia Hay Fever Drug Market Size, 2018-2029
6.6.7 India Hay Fever Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hay Fever Drug Revenue, 2018-2029
6.7.2 By Country – South America Hay Fever Drug Sales, 2018-2029
6.7.3 Brazil Hay Fever Drug Market Size, 2018-2029
6.7.4 Argentina Hay Fever Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hay Fever Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hay Fever Drug Sales, 2018-2029
6.8.3 Turkey Hay Fever Drug Market Size, 2018-2029
6.8.4 Israel Hay Fever Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Hay Fever Drug Market Size, 2018-2029
6.8.6 UAE Hay Fever Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer Healthcare
7.1.1 Bayer Healthcare Company Summary
7.1.2 Bayer Healthcare Business Overview
7.1.3 Bayer Healthcare Hay Fever Drug Major Product Offerings
7.1.4 Bayer Healthcare Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Healthcare Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Hay Fever Drug Major Product Offerings
7.2.4 Novartis Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Merck& Co inc
7.3.1 Merck& Co inc Company Summary
7.3.2 Merck& Co inc Business Overview
7.3.3 Merck& Co inc Hay Fever Drug Major Product Offerings
7.3.4 Merck& Co inc Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.3.5 Merck& Co inc Key News & Latest Developments
7.4 Zicam LLC
7.4.1 Zicam LLC Company Summary
7.4.2 Zicam LLC Business Overview
7.4.3 Zicam LLC Hay Fever Drug Major Product Offerings
7.4.4 Zicam LLC Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.4.5 Zicam LLC Key News & Latest Developments
7.5 F.Hoffman La Roche
7.5.1 F.Hoffman La Roche Company Summary
7.5.2 F.Hoffman La Roche Business Overview
7.5.3 F.Hoffman La Roche Hay Fever Drug Major Product Offerings
7.5.4 F.Hoffman La Roche Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.5.5 F.Hoffman La Roche Key News & Latest Developments
7.6 Ache Laboratories
7.6.1 Ache Laboratories Company Summary
7.6.2 Ache Laboratories Business Overview
7.6.3 Ache Laboratories Hay Fever Drug Major Product Offerings
7.6.4 Ache Laboratories Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.6.5 Ache Laboratories Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Hay Fever Drug Major Product Offerings
7.7.4 GlaxoSmithKline Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 ARIUS FORMULATIONS PVT LTD
7.8.1 ARIUS FORMULATIONS PVT LTD Company Summary
7.8.2 ARIUS FORMULATIONS PVT LTD Business Overview
7.8.3 ARIUS FORMULATIONS PVT LTD Hay Fever Drug Major Product Offerings
7.8.4 ARIUS FORMULATIONS PVT LTD Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.8.5 ARIUS FORMULATIONS PVT LTD Key News & Latest Developments
7.9 Cipla
7.9.1 Cipla Company Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Hay Fever Drug Major Product Offerings
7.9.4 Cipla Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.9.5 Cipla Key News & Latest Developments
7.10 Allergan
7.10.1 Allergan Company Summary
7.10.2 Allergan Business Overview
7.10.3 Allergan Hay Fever Drug Major Product Offerings
7.10.4 Allergan Hay Fever Drug Sales and Revenue in Global (2018-2023)
7.10.5 Allergan Key News & Latest Developments
8 Global Hay Fever Drug Production Capacity, Analysis
8.1 Global Hay Fever Drug Production Capacity, 2018-2029
8.2 Hay Fever Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Hay Fever Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hay Fever Drug Supply Chain Analysis
10.1 Hay Fever Drug Industry Value Chain
10.2 Hay Fever Drug Upstream Market
10.3 Hay Fever Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hay Fever Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の花粉症治療薬市場予測2023-2029：スプレー、ドロップ、ジェル |
| 【英語タイトル】Hay Fever Drug Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5603 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：71 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の花粉症治療薬市場規模と予測を収録しています。・世界の花粉症治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の花粉症治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の花粉症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「スプレー」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 花粉症治療薬のグローバル主要企業は、Bayer Healthcare、 Novartis、 Merck& Co inc、 Zicam LLC、 F.Hoffman La Roche、 Ache Laboratories、 GlaxoSmithKline、 ARIUS FORMULATIONS PVT LTD、 Cipla、 Allerganなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、花粉症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の花粉症治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の花粉症治療薬市場：タイプ別市場シェア、2022年 ・スプレー、ドロップ、ジェル 世界の花粉症治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の花粉症治療薬市場：用途別市場シェア、2022年 ・病院、クリニック、その他 世界の花粉症治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の花粉症治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における花粉症治療薬のグローバル売上、2018年-2023年 ・主要企業における花粉症治療薬のグローバル売上シェア、2022年 ・主要企業における花粉症治療薬のグローバル販売量、2018年-2023年 ・主要企業における花粉症治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Bayer Healthcare、 Novartis、 Merck& Co inc、 Zicam LLC、 F.Hoffman La Roche、 Ache Laboratories、 GlaxoSmithKline、 ARIUS FORMULATIONS PVT LTD、 Cipla、 Allergan ************************************************************* ・調査・分析レポートの概要 花粉症治療薬市場の定義 市場セグメント 世界の花粉症治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の花粉症治療薬市場規模 世界の花粉症治療薬市場規模：2022年 VS 2029年 世界の花粉症治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの花粉症治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の花粉症治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：スプレー、ドロップ、ジェル 花粉症治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック、その他 花粉症治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別花粉症治療薬市場規模 2022年と2029年 地域別花粉症治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Bayer Healthcare、 Novartis、 Merck& Co inc、 Zicam LLC、 F.Hoffman La Roche、 Ache Laboratories、 GlaxoSmithKline、 ARIUS FORMULATIONS PVT LTD、 Cipla、 Allergan ... |
Antihistamines are medicines often used to relieve symptoms of allergies, such as hay fever, hives, conjunctivitis and reactions to insect bites or stings.
This report aims to provide a comprehensive presentation of the global market for Hay Fever Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hay Fever Drug. This report contains market size and forecasts of Hay Fever Drug in global, including the following market information:
Global Hay Fever Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hay Fever Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hay Fever Drug companies in 2022 (%)
The global Hay Fever Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Sprays Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hay Fever Drug include Bayer Healthcare, Novartis, Merck& Co inc, Zicam LLC, F.Hoffman La Roche, Ache Laboratories, GlaxoSmithKline, ARIUS FORMULATIONS PVT LTD and Cipla, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hay Fever Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hay Fever Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hay Fever Drug Market Segment Percentages, by Type, 2022 (%)
Sprays
Drops
Gels
Global Hay Fever Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hay Fever Drug Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Hay Fever Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hay Fever Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hay Fever Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hay Fever Drug revenues share in global market, 2022 (%)
Key companies Hay Fever Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hay Fever Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare
Novartis
Merck& Co inc
Zicam LLC
F.Hoffman La Roche
Ache Laboratories
GlaxoSmithKline
ARIUS FORMULATIONS PVT LTD
Cipla
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hay Fever Drug, market overview.
Chapter 2: Global Hay Fever Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Hay Fever Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hay Fever Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hay Fever Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の花粉症治療薬市場予測2023-2029：スプレー、ドロップ、ジェル] (コード：MMG23JU5603)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の花粉症治療薬市場予測2023-2029：スプレー、ドロップ、ジェル]についてメールでお問い合わせ |
